CatchMark Timber Trust, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- CatchMark Timber Trust, Inc. (NYSE: CTT) operates as a real estate investment trust focused on the ownership, acquisition, management, and disposition of timberlands located primarily in the U.S. South; the company offers timber sales including sawtimber, pulpwood, wood chips, sawdust, and bark; wood by-products for industrial, biomass energy, and landscaping applications; real estate services such as hunting lease access, conservation easements, and recreational opportunities; and land management consulting encompassing sustainable forestry practices, timber inventory analysis, harvest planning, reforestation, growth optimization, acquisition advisory, sales optimization, and estate planning. Headquartered in Atlanta, Georgia, and founded in 2005 with operations commencing in 2006 or 2007, CatchMark targets high-quality timberlands in leading mill markets to deliver sustainable yields through disciplined stewardship and ecosystem sustainability. In September 2022, CatchMark merged with a wholly owned subsidiary of PotlatchDeltic Corporation (NASDAQ: PCH) in an all-stock transaction, creating a leading integrated timber REIT, after which CatchMark's common stock ceased public trading and its ticker transitioned under PotlatchDeltic. Prior to the merger, the company pursued strategic timberland transactions, including a 2018 joint venture acquisition of 1.1 million acres in East Texas for $1.39 billion with BTG Pactual Timberland Investment Group and partners, and post-merger activities such as the 2023 purchase of 18,063 acres in Oregon known as the Brandon Property focused on Douglas fir sawtimber.
CTT Pharma Corporate Updates
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology
CTT Pharma Receives SEC Approval
CTT Pharma Signs LOI with European Company
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
CTT Pharma's CEO will issue a Letter to Shareholders
CTT Pharma Signs Contract for $3 Million Equity Line of Credit
Correios De Portugal: A Surprising Buy On E-Commerce Growth Despite Mail Delivery Drag
CTT - Correios De Portugal, S.A. (CTTPY) Q1 2024 Earnings Call Transcript
CTT - Correios De Portugal, S.A. (CTTPY) Q4 2023 Earnings Call Transcript
CTT - Correios De Portugal, S.A. (CTTPY) Q3 2023 Earnings Call Transcript
CTT - Correios De Portugal, S.A. (CTTPY) Q2 2023 Earnings Call Transcript
PotlatchDeltic Announces Tax Treatment for CatchMark's 2022 Dividend Distributions
CTT - Correios De Portugal, S.A. (CTTPY) Q3 2022 Earnings Call Transcript
CatchMark Timber Trust, Inc. Stockholders Approve Merger with PotlatchDeltic Corporation
CatchMark Timber Trust Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote "FOR" Proposed Merger of CatchMark with PotlatchDeltic Corporation
These dividend stocks can protect you as the Federal Reserve slows the economy
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HMTV, CTT, ZEN
CATCHMARK TIMBER INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CatchMark Timber Trust, Inc. - CTT
CatchMark (CTT) Reports Q2 Loss, Tops Revenue Estimates